Apyx Medical Corporation to Participate in Upcoming November Investor Conferences
Apyx Medical (NASDAQ:APYX) announced that President and CEO Charles Goodwin and CFO Matt Hill will attend investor meetings in New York in November 2025.
They will participate in 1x1 meetings at the 16th Annual Craig-Hallum Alpha Select Conference on November 18, 2025 at Sheraton NY Times Square, and at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 20, 2025 at Westin NY Grand Central.
Investors seeking meetings should contact their Craig Hallum or Canaccord Genuity representatives. The release also restates the company’s Helium Plasma Platform products (Renuvion, AYON Body Contouring System, J-Plasma), notes >90 clinical documents supporting Renuvion and J-Plasma, and describes AYON as FDA-cleared.
Apyx Medical (NASDAQ:APYX) ha annunciato che il presidente e CEO Charles Goodwin e il CFO Matt Hill parteciperanno a incontri con investitori a New York nel novembre 2025.
Parteciperanno a incontri individuali al 16th Annual Craig-Hallum Alpha Select Conference il 18 novembre 2025 presso il Sheraton NY Times Square, e al Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum il 20 novembre 2025 presso il Westin NY Grand Central.
Gli investitori interessati a incontri dovrebbero contattare i rappresentanti di Craig Hallum o Canaccord Genuity. Il comunicato evidenzia anche i prodotti della Helium Plasma Platform (Renuvion, AYON Body Contouring System, J-Plasma), oltre 90 documenti clinici a supporto di Renuvion e J-Plasma, e descrive AYON come approvato dalla FDA.
Apyx Medical (NASDAQ:APYX) anunció que el presidente y CEO Charles Goodwin y el director financiero Matt Hill asistirán a reuniones con inversionistas en Nueva York en noviembre de 2025.
Participarán en reuniones 1x1 en la 16th Annual Craig-Hallum Alpha Select Conference el 18 de noviembre de 2025 en el Sheraton NY Times Square, y en el Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum el 20 de noviembre de 2025 en el Westin NY Grand Central.
Los inversionistas que deseen reuniones deben contactar a sus representantes de Craig Hallum o Canaccord Genuity. El comunicado también reafirma los productos de la Helium Plasma Platform (Renuvion, AYON Body Contouring System, J-Plasma), destaca más de 90 documentos clínicos que respaldan a Renuvion y J-Plasma y describe AYON como aprobado por la FDA.
Apyx Medical (NASDAQ:APYX) 는 회장 겸 CEO Charles Goodwin 와 CFO Matt Hill 가 2025년 11월 뉴욕에서 투자자 미팅에 참석할 것이라고 발표했습니다.
그들은 2025년 11월 18일 Sheraton NY Times Square에서 열리는 제16회 Craig-Hallum Alpha Select Conference의 1대1 미팅과 2025년 11월 20일 Westin NY Grand Central에서 개최되는 Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum에 참석할 예정입니다.
투자자들은 미팅을 원하면 Craig Hallum 또는 Canaccord Genuity의 대표들에게 연락해야 합니다. 발표문은 Helium Plasma Platform 제품군(Renuvion, AYON Body Contouring System, J-Plasma)을 다시 언급하고, Renuvion과 J-Plasma를 지원하는 90건이 넘는 임상 문서를 밝히며 AYON이 FDA 승인을 받았다고 설명합니다.
Apyx Medical (NASDAQ:APYX) a annoncé que le président et PDG Charles Goodwin et le directeur financier Matt Hill assisteront à des réunions avec des investisseurs à New York en novembre 2025.
Ils participeront à des entretiens individuels lors de la 16th Annual Craig-Hallum Alpha Select Conference le 18 novembre 2025 au Sheraton NY Times Square et au Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum le 20 novembre 2025 au Westin NY Grand Central.
Les investisseurs souhaitant des réunions doivent contacter leurs représentants Craig Hallum ou Canaccord Genuity. Le communiqué rappelle également les produits de la Helium Plasma Platform (Renuvion, AYON Body Contouring System, J-Plasma), mentionne plus de 90 documents cliniques à l’appui de Renuvion et J-Plasma et décrit AYON comme étant approuvé par la FDA.
Apyx Medical (NASDAQ:APYX) gab bekannt, dass der Präsident und CEO Charles Goodwin und der CFO Matt Hill an Investorentreffen in New York im November 2025 teilnehmen werden.
Sie werden an 1-zu-1-Gesprächen auf der 16th Annual Craig-Hallum Alpha Select Conference am 18. November 2025 im Sheraton NY Times Square teilnehmen, sowie am Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum am 20. November 2025 im Westin NY Grand Central.
Investoren, die Meetings wünschen, sollten sich an ihre Vertreter von Craig Hallum oder Canaccord Genuity wenden. Die Pressemitteilung wiederholt außerdem die Produkte der Helium Plasma Platform (Renuvion, AYON Body Contouring System, J-Plasma), verweist auf mehr als 90 klinische Unterlagen, die Renuvion und J-Plasma unterstützen, und beschreibt AYON als FDA-zugelassen.
Apyx Medical (NASDAQ:APYX) أعلنت أن رئيسها التنفيذي Charles Goodwin والرئيس المالي Matt Hill سيحضران اجتماعات المستثمرين في نيويورك في نوفمبر 2025.
سيشاركان في لقاءات فردية في 16th Annual Craig-Hallum Alpha Select Conference في 18 نوفمبر 2025 في فندق Sheraton NY Times Square، وفي Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum في 20 نوفمبر 2025 في Westin NY Grand Central.
يتعين على المستثمرين الراغبين في الاجتماع الاتصال بممثلي Craig Hallum أو Canaccord Genuity. كما يعيد البيان ذكر منتجات Helium Plasma Platform (Renuvion, AYON Body Contouring System, J-Plasma)، ويشير إلى أكثر من 90 وثيقة سريرية تدعم Renuvion وJ-Plasma، ويصف AYON بأنه معتمد من FDA.
Apyx Medical (NASDAQ:APYX) 宣布，董事長兼首席執行官 Charles Goodwin 與首席財務官 Matt Hill 將於 2025 年 11 月在紐約出席投資者會議。
他們將於 2025 年 11 月 18 日 在 Sheraton NY Times Square 參加 第16屆 Craig-Hallum Alpha Select Conference 的一對一會談，並於 2025 年 11 月 20 日 在 Westin NY Grand Central 參加 Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum。
尋求會議的投資者應联系他們在 Craig Hallum 或 Canaccord Genuity 的代表。公告中還重申了 Helium Plasma Platform 的產品（Renuvion、AYON Body Contouring System、J-Plasma），提及支持 Renuvion 和 J-Plasma 的超過 90 份臨床文件，並描述 AYON 已獲 FDA 批准。
- None.
- None.
CLEARWATER, Fla., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion® and the AYON Body Contouring System™, today announced that Charles Goodwin, President and CEO and Matt Hill, CFO will be attending the following upcoming conferences:
Event: 16th Annual Craig-Hallum Alpha Select Conference
Date: Tuesday, November 18, 2025
Location: Sheraton NY Times Square Hotel, New York, NY
Format: 1x1 Meetings
Event: Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
Date: Thursday, November 20, 2025
Location: Westin NY Grand Central, New York, NY
Format: 1x1 Meetings
To request a meeting with Apyx, investors should contact their Craig Hallum and Canaccord Genuity representatives.
About Apyx Medical Corporation:
Apyx Medical Corporation is an advanced energy technology company with a passion for elevating people’s lives through innovative products, including its Helium Plasma Platform Technology products marketed and sold as Renuvion® and the AYON Body Contouring System™ in the cosmetic surgery market and J-Plasma® in the hospital surgical market. Renuvion and J-Plasma offer surgeons a unique ability to provide controlled heat to tissue to achieve their desired results. The effectiveness of Renuvion and J-Plasma are supported by more than 90 clinical documents. The AYON Body Contouring System™ is an FDA-cleared, groundbreaking, surgeon-designed body contouring system that combines precision, versatility, and innovation in an all-in-one platform. It seamlessly integrates fat removal, closed loop contouring, tissue contraction, and electrosurgical capabilities, empowering surgeons to deliver the most comprehensive body contouring treatments for patients. The Company also leverages its deep expertise and decades of experience in unique waveforms through OEM agreements with other medical device manufacturers. For further information about the Company and its products, please refer to the Apyx Medical Corporation website at www.ApyxMedical.com
Investor Relations Contact:
Jeremy Feffer
Managing Director
LifeSci Advisors
OP: 212-915-2568
jfeffer@lifesciadvisors.com
FAQ
When will Apyx Medical (APYX) management meet investors in New York in November 2025?
Who from Apyx Medical (APYX) will attend the November 2025 investor conferences?
Which events will Apyx Medical (APYX) attend on November 18 and 20, 2025?
How can investors request a meeting with Apyx Medical (APYX) at the November 2025 conferences?
What Apyx Medical (APYX) products were highlighted in the November 27, 2025 announcement?
Is the AYON Body Contouring System from Apyx Medical (APYX) FDA-cleared?
